Diet Pill Maker Orexigen Losing Race to Profits

PHARMA: Unable to Go It Alone, Co. Pursues Strategic Alternatives

Diet pill maker Orexigen Therapeutics, one of San Diego’s struggling public companies, may soon auction itself off to the highest bidder in an attempt to fortify its finances.

Tease photo

Acutus Medical Imaging Tech Receives FDA clearance

The FDA has cleared Carlsbad-based Acutus Medical’s AcQMap system.

NuVasive Reports Q3 Results

Spine surgery and medical device company NuVasive reported solid revenue growth in its third quarter earnings report, driven by strong international sales.

Neighborhood Healthcare’s Longtime CEO Retires, Successor Named

Neighborhood Healthcare, which has 12 health centers in San Diego and Riverside, has tapped Rakesh Patel as its new CEO.

Ignyta Inc. Raises $160 Million in New Stock Offering

San Diego drugmaker Ignyta Inc. is piggybacking off recent positive press by raising $160 million in a new stock offering.

FDA Gives Special Classification to Neurocrine Biosciences Drug

Regulators with the U.S. Food and Drug Administration have handed Neurocrine Biosciences a special classification for one of its drug programs, granting the company a number of perks.

Mirati’s Cancer Drug Lifts Stock, While Otonomy Hears Bad News

BIOTECH: Collectively Stocks Up 4% But Gains Not Spread Equally

The stock performance of San Diego’s public life science companies saw a modest gain in the third quarter, with a few high-performing drugmakers pulling up the region’s average.

Tease photo

NuVasive Launches 3D-Printed Titanium Implant

Medical device and surgery company NuVasive has launched Modulus XLIF, titanium implants that are 3-D-printed, expanding the company’s surgical offerings.

Arcturus Therapeutics Partnering With Pharma Giant on Infectious Diseases

Arcturus Therapeutics Inc., a small local biotech that reversed its way into the public markets a few weeks ago, has struck a comprehensive research deal with pharmaceutical giant Johnson & Johnson.

CareFusion to Lay Off Up to 81 Employees in San Diego

Medical device maker CareFusion will eliminate about 81 positions in San Diego as part of a strategic shift.

Ionis Earns $10M Milestone Payment From Biogen

Carlsbad drugmaker Ionis Pharmaceuticals has earned $10 million from its Big Pharma partner Biogen for taking one of its experimental drugs to the clinic.

Evofem Biosciences, Neothetics Announce Merger Agreement

Following its failure in the clinic, San Diego’s fat-busting biotech Neothetics is folding into a growing local company called Evofem Biosciences.

Illumina Ventures Raises $230M Fund to Support Genomics Startups

The venture capital firm founded by San Diego’s DNA instrument giant Illumina Inc. has raised a $230 million fund to fuel genomics startups.

Shelved Drug's Prospects Revived With $22M

Last year, a top San Diego executive snatched up a once-failed drug from pharma giant Sanofi and formed a new biotech startup around the medicine.k

AnaptysBio Plans to Raise $99M in Stock Offering

Local biotech AnaptysBio is capitalizing on its skyrocketing stock performance this week with an announcement that the company plans to raise $99 million in a stock offering this month.